Moderate riskFDA DrugClass II

Wegovy injection recalled for particulate matter in syringe

Novo Nordisk discovered hair in some prefilled Wegovy injection pens. This affects specific lot numbers manufactured in Denmark. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your Wegovy pen for lot number RZFHD52 or RZFHW93 (expiration 10/31/2026)
  2. Do not use affected pens
  3. Contact your pharmacy or doctor for a replacement
  4. Call Novo Nordisk customer service if you have questions

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
800 Scudders Mill Rd, N/A, Plainsboro, NJ, United States
Classification
Class II
Recall number
D-0244-2026

In the FDA's words

Description
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14 Presence of Particulate Matter: Hair was found in a prefilled syringe Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026 Distribution: Nationwide within the United States. Affected quantity: N/A
Hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe

2 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug